Oxidative stress and apoptosis in heart dysfunction

Dinender Kumar1, Huiquan Lou, Pawan K Singal

  • 1Cardiovascular Research Group, Department of Medicine, University of Wisconsin, Madison, WI, USA.

Herz
|November 20, 2002
PubMed

Insights

Antioxidants show promise in treating heart disease by inhibiting apoptosis, a process causing myocyte cell loss. This discovery offers new therapeutic avenues for cardiovascular conditions.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • Heart disease pathogenesis involves complex mechanisms, including myocyte cell loss via apoptosis.
  • Apoptosis is implicated in myocardial infarction, ischemia-reperfusion injury, heart failure, and cardiomyopathy.

Purpose of the Study:

  • To elucidate the role of apoptosis in cardiac dysfunction.
  • To investigate the regulatory processes of apoptosis in the heart.
  • To explore potential therapeutic targets for heart disease.

Main Methods:

  • Review of documented apoptotic regulatory pathways in cardiac disease.
  • Analysis of pro-apoptotic (Bax, caspases, cytochrome c) and anti-apoptotic (Bcl-2, Akt, IAPs) protein expression.
  • Investigation of the role of mitogen-activated protein kinases (MAPKs) in apoptosis and survival.
  • Evaluation of oxidative stress and antioxidant effects on apoptotic pathways.

Main Results:

  • Upregulation of pro-apoptotic proteins and/or downregulation of anti-apoptotic proteins are observed in cardiac diseases.
  • Mitogen-activated protein kinases (MAPKs) play a dual role in apoptosis and cell survival.
  • Inhibition of apoptotic pathways (e.g., caspase inhibitors, Bcl-2, Akt overexpression) can block apoptosis.
  • Oxidative stress promotes apoptosis, while antioxidants inhibit this process.

Conclusions:

  • Antioxidants demonstrate potential in inhibiting apoptotic pathways.
  • This finding suggests novel therapeutic strategies for treating various heart diseases.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Cellular Injury I: Introduction01:00

Cellular Injury I: Introduction

Cellular injury occurs when a cell cannot maintain homeostasis or adapt to stressors such as hypoxia, toxins, or trauma. Depending on severity and duration, injury may be reversible, allowing recovery, or irreversible, leading to cell death.General Mechanisms of Cell InjuryAlthough causes vary, most cellular injuries arise from a few key mechanisms that disrupt essential functions and often amplify one another. Cell survival depends on the extent and balance of these disturbances.ATP depletion...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...